Gerardo Heredia Melero, MD
Urogynecology and Reconstructive Pelvic Surgery · Lexington, KYNPI 1174839401
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,691 of the $4,183 with a category attached, or 64.3%. Axonics, Inc. accounts for 89.8% of it on its own, with 4 other manufacturers making up the rest.
Across 35 payments — averaging $119.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$4K
- Medtronic$354
- Boston Scientific$28
- Applied Medical Resources Corporation$22
- Intuitive Surgical$22
What the payments were for
- Travel & lodging$2,69164%
- Food & beverage$1,49236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 29 | $3,756 |
| Medtronic(2 entities) | 3 | $354 |
| Boston Scientific | 1 | $28 |
| Applied Medical Resources Corporation | 1 | $22 |
| Intuitive Surgical | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 56 | $51,126 |
| MyrbetriqMirabegron | 38 | $30,254 |
| Mirabegron ErMirabegron | 14 | $9,183 |
| Estradiol | 86 | $8,168 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $1,327 |
| Methenamine Hippurate | 20 | $1,093 |
| Bethanechol Chloride | 12 | $728 |
| Solifenacin Succinate | 11 | $670 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $367 |
| Cephalexin | 28 | $277 |
| Gabapentin | 12 | $68 |
| Fluconazole | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Lexington
- Shubham GuptaLexington$8K
- Susan OakleyEdgewood$23K
- Parisa SamimiBowling Green$9K
- Caroline Elmer-LyonEdgewood$7K
- Sarah KaneLouisville$5K
- Jenna WarehimeLouisville$4K
- Majorie PilkintonLouisville$3K
- Susan TateLouisville$2K
- Andrew DoeringLouisville$2K
- Kurt JaenickeLouisa$134
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.